Junjie Li

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: September 03, 2026

The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer.

The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer.

Journal: Cancer biology & medicine
Published: July 14, 2026

Profiling RNA subcellular localization in situ by TATA-seq.

Profiling RNA subcellular localization in situ by TATA-seq.

Journal: RNA (New York, N.Y.)
Published: February 02, 2025

Personalized Trastuzumab-Induced Cardiac Dysfunction Risk Stratification and Surveillance.

Personalized Trastuzumab-Induced Cardiac Dysfunction Risk Stratification and Surveillance.

Journal: JACC. CardioOncology
Published: January 07, 2025

SRSF10 regulates oligodendrocyte differentiation during mouse central nervous system development by modulating pre-mRNA splicing.

SRSF10 regulates oligodendrocyte differentiation during mouse central nervous system development by modulating pre-mRNA splicing.

Journal: Nucleic acids research
Published: September 03, 2024

Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.

Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: August 14, 2024

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

Journal: EClinicalMedicine
Published: April 17, 2024

SRSF10 regulates migration of neural progenitor cells and granule cells and affects the formation of dentate gyrus during the development of mouse hippocampus.

SRSF10 regulates migration of neural progenitor cells and granule cells and affects the formation of dentate gyrus during the development of mouse hippocampus.

Journal: Neuroscience
Published: April 03, 2024

Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis.

Tailoring Escalation Adjuvant Therapy for Early-Stage Triple-Negative Breast Cancer in the CBCSG010 Clinical Trial Biomarker Analysis.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 21, 2023

SRSF10 regulates proliferation of neural progenitor cells and affects neurogenesis in developing mouse neocortex.

SRSF10 regulates proliferation of neural progenitor cells and affects neurogenesis in developing mouse neocortex.

Journal: iScience
Published: January 09, 2023

Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial.

Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial.

Journal: Cancer biology & medicine
Published: July 21, 2022

Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis.

Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis.

Journal: Cancer biology & medicine
Published: February 16, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026